The mounting of somatically mutated high affinity antibody responses is important in protection against a range of pathogens and underlies the success of most vaccine strategies. As well as their beneficial functions, GCs are the source of a major class of lymphoma. The interactions between GC B cells and stromal cells in the GC niche that support events necessary for GC B cell selection and survival are incompletely understood as are the mechanisms promoting GC B cell growth regulation and confinement. The research proposed in this application will advance knowledge in both of these areas. First, the properties of a newly identified stromal cell type, termed CXCL12-expressing reticular cells (CRCs), present within GCs will be investigated. The phenotype and developmental requirements of CRCs will be studied, the dynamics of GC B cell interaction with this new component of the GC niche tracked using intravital 2-photon microscopy, and the functional roles of the cells will be probed. Their role in positioning CXCR4-expressing follicular helper T cells, as well as GC B cells, will be investigated. Second, the mechanism of G?13-mediated regulation of GC B cell growth and migration will be dissected. One receptor-ligand interaction important for transmitting G?13- signals that control GC B cell growth and confinement is that between the lysophospholipid sphingosine-1-phosphate (S1P) and its receptor S1PR2. Both G?13and S1PR2 are frequently mutated in human GC B cell-type diffuse large B cell lymphoma (GCB-DLBCL) and loss of either gene is sufficient to predispose mice to this malignancy. Although GC B cells are non-recirculatory, GCB-DLBCL presents as a systemic disease. Preliminary data show that G?13-deficiency in mice is sufficient to cause a loss of GC B cell confinement and allow GC B cells to enter circulation. S1PR2-deficiency, however, does not lead to GC B cell dissemination. These observations have led to the discovery that an orphan G-protein coupled receptor (GPCR) that is frequently mutated in GCB-DLBCL, P2RY8, also promotes GC B cell growth regulation and confinement by engaging G?13. A major goal of this proposal is to define the expression and function of this novel human GPCR, and the mechanism of G?13-mediated GC B cell confinement in GCs. Mounting appropriately regulated immune responses is essential for human health. This work will define how a new stromal cell type supports GC B cell somatic mutation and selection events necessary for generating highly mutated antibodies such as those capable of mediating broadly neutralizing responses against influenza and HIV-1 antigens. The research will build from evidence that S1PR2 and G?13function in a tumor suppressor and dissemination-inhibitory pathway in GCB-DLBCL to define the role of a new receptor, P2RY8, in this process. These studies are anticipated to have implications for development of new treatment strategies for this malignancy.

Public Health Relevance

B cell responses in germinal centers are critical for protection against pathogens, are a cause of pathogenesis in autoimmune diseases, and their dysregulation underlies common B cell lymphomas. The proposed studies should lead to an improved understanding of how selection of high affinity B cells occurs in germinal centers and how these responses are kept in check, knowledge that has implications for development of improved vaccines and may suggest novel approaches for reducing unwanted responses to autoantigens or allergens. The work has the potential to lead to new treatment strategies for germinal center-type diffuse large B cell lymphoma.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI045073-16A1
Application #
8814857
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Ferguson, Stacy E
Project Start
1999-04-01
Project End
2019-08-31
Budget Start
2014-09-17
Budget End
2015-08-31
Support Year
16
Fiscal Year
2014
Total Cost
$355,688
Indirect Cost
$130,688
Name
University of California San Francisco
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Reboldi, Andrea; Cyster, Jason G (2016) Peyer's patches: organizing B-cell responses at the intestinal frontier. Immunol Rev 271:230-45
Wu, Shuang; Majeed, Sophia R; Evans, Timothy M et al. (2016) Clathrin light chains' role in selective endocytosis influences antibody isotype switching. Proc Natl Acad Sci U S A 113:9816-21
Reboldi, Andrea; Arnon, Tal I; Rodda, Lauren B et al. (2016) IgA production requires B cell interaction with subepithelial dendritic cells in Peyer's patches. Science 352:aaf4822
Bannard, Oliver; McGowan, Simon J; Ersching, Jonatan et al. (2016) Ubiquitin-mediated fluctuations in MHC class II facilitate efficient germinal center B cell responses. J Exp Med 213:993-1009
Muppidi, Jagan R; Lu, Erick; Cyster, Jason G (2015) The G protein-coupled receptor P2RY8 and follicular dendritic cells promote germinal center confinement of B cells, whereas S1PR3 can contribute to their dissemination. J Exp Med 212:2213-22
Barnes, Michael J; Li, Chien-Ming; Xu, Ying et al. (2015) The lysophosphatidylserine receptor GPR174 constrains regulatory T cell development and function. J Exp Med 212:1011-20
Rodda, Lauren B; Bannard, Oliver; Ludewig, Burkhard et al. (2015) Phenotypic and Morphological Properties of Germinal Center Dark Zone Cxcl12-Expressing Reticular Cells. J Immunol 195:4781-91
Muppidi, Jagan R; Schmitz, Roland; Green, Jesse A et al. (2014) Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma. Nature 516:254-8
Wang, Xiaoming; Rodda, Lauren B; Bannard, Oliver et al. (2014) Integrin-mediated interactions between B cells and follicular dendritic cells influence germinal center B cell fitness. J Immunol 192:4601-9
Gray, Elizabeth E; Ramírez-Valle, Francisco; Xu, Ying et al. (2013) Deficiency in IL-17-committed Vγ4(+) γδ T cells in a spontaneous Sox13-mutant CD45.1(+) congenic mouse substrain provides protection from dermatitis. Nat Immunol 14:584-92

Showing the most recent 10 out of 52 publications